11 December 2025 DARPA’s FSHARP Program Manager visits NAMRU San Antonio, tours Research Laboratories JOINT BASE SAN ANTONIO-FORT SAM HOUSTON – Dr. Jeremy Pamplin, program manager, Biological Technologies Office, Defense Advanced Research Projects Agency (DARPA), visited with leadership and research scientists assigned to Naval Medical Research Unit (NAMRU) San Antonio at the Battlefield Health &...
11 December 2025 NAMRU EURAFCENT Strengthens Force Health Readiness with Advancement in Diarrheal Disease Treatment CAMP LEMONNIER, Djibouti – This fall, a team of researchers and leadership with Naval Medical Research Unit (NAMRU) EURAFCENT engaged with strategic U.S. military partners to improve surveillance of and refine treatment for infectious diarrheal diseases, a persistent operational challenge impacting...
21 November 2025 NSMRL Divers Take Part in Hartford-Springfield Navy Week SPRINGFIELD, Mass. – Sailors from Naval Submarine Medical Research Laboratory (NSMRL) participated in the Big E festival during the inaugural Hartford-Springfield Navy Week portion of the event on Sept. 25.Navy Week volunteers set up booths near the main entertainment stage to engage with visitors...
20 November 2025 NMRC Researchers Submit Provisional Patent for Nanoparticle Vaccine SILVER SPRING, Md. – Researchers at Naval Medical Research Command (NMRC) submitted a provisional patent for a nanoparticle vaccine to the U.S. Patent and Trademark Office on September 9. This vaccine development method is intended to prevent malaria but can also be used to develop vaccines against...
18 November 2025 NSMRL Diver Recognized as Chamber of Commerce of Eastern CT Serviceperson of the Year NEW LONDON, Conn. – Navy Diver 1st Class John Ahnen with Naval Submarine Medical Research Laboratory (NSMRL) was recognized by the Chamber of Commerce of Eastern Connecticut as their 2024-2025 Serviceperson of the Year (SPOY).The SPOY award honors exceptional active-duty, reserve, or National Guard...
30 September 2025 NMRC Researchers Conduct First in Human Clinical Trials for Staph A Treatment BETHESDA, Md. – Naval Medical Research Command (NMRC) staff recruited 129 volunteers to participate in a phase 1, first-in-human, FDA clinical trial for a Staphylococcus aureus (Staph) treatment at the command’s Clinical Trials Center (CTC).The trial, consisting of military and civilian volunteer...